CClinicalTrials.gg
CompletedNCT02153242PacingRVUpdated Dec 22, 2020

The Effects of Selective Site Right Ventricular Pacing

An observational study in Bradycardia, sponsored by Mid and South Essex NHS Foundation Trust. Completed at 1 site in United Kingdom. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2020-12-22.

Sponsored by Mid and South Essex NHS Foundation Trust · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
14
Ages
18 Years to 80 Years
Sex
All
01

Study summary

This is a pilot study into the effects on heart function when pacing the right ventricle (RV). This study aims to enrol a population with structurally normal hearts. The investigators aim to measure heart function directly when pacing.

When normal conduction within the heart fails, the treatment may be to implant a permanent pacemaker. Pacing involves passing a lead via a vein to the heart and using an electrical impulse to stimulate a beat. The usual site for pacing is the tip of the RV. This has been shown to be less efficient than the normal conduction system of the heart and in some cases leads to markedly reduced function. What the investigators do not know is why this is the case.

Much effort has been directed at looking at features within the left ventricle (LV) for markers of disease progression but little has been investigated regarding the RV.

There may be some benefit to pacing the heart preferentially from different parts of the RV and the investigators aim to measure if any differences are detectable from stimulating the heart at various sites within the RV.

Read the detailed description

Inclusion Criteria;

  • Patients undergoing elective Electrophysiological Studies +/Ablation
  • Age 18-80
  • Normal Heart on Pre-procedural Echocardiogram

Exclusion criteria;

  • Atrial Fibrillation
  • Evidence of anterograde conducting accessory pathway
  • Permanent Pacemaker insitu
  • Pregnant
  • Breast Feeding

Outcome Measures; Change in load-independent indices of LV and RV contractility before and after pacing intervention. LV and RV function measured by transthoracic echocardiography and tissue Doppler imaging.

02

Conditions studied

  • Bradycardia

Browse trials for

Keywords

  • Pacing
  • Haemodynamics
  • Pilot
03

In context

Bradycardia

306 studies on the registry are indexed under Bradycardia; 69 are open to participants now.

This study's enrollment of 14 is below the median of 257 across 129 observational studies indexed under Bradycardia.

Browse Bradycardia studies →

Lead sponsor

Mid and South Essex NHS Foundation Trust is the lead sponsor of 34 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients undergoing SVT studies

Inclusion criteria

  • Patients undergoing elective Electrophysiological Studies +/Ablation
  • Age 18-80
  • Normal Heart on Pre-procedural Echocardiogram

Exclusion criteria

Exclusion criteria:

  • Atrial Fibrillation
  • Evidence of anterograde conducting accessory pathway
  • Permanent Pacemaker insitu
  • Pregnant
  • Breast Feeding
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
14 participants (actual)
Patient registry
No

Groups and cohorts

  • Supra Ventricular Tachycardia (SVT)

    Patients undergoing SVT studies

06

What researchers measure

Primary outcomes

  1. Ventricular Function

    Measurement of both right and left ventricular function under differing pacing conditions

    Time frame: 30 minutes

07

Study locations

1 site
  • The Essex Cardiothoracic Centre
    Basildon, Essex SS16 5NL, United Kingdom
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 22, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02153242
Lead sponsor
Mid and South Essex NHS Foundation Trust
Responsible party
Sponsor
First posted
Jun 3, 2014
Start date
Sep 2013
Primary completion
Jun 2015
Completion
Jun 2015
Last update
Dec 22, 2020

Study contacts

Stuart Tan
principal investigator · Basildon & Thurrock University Hospital NHS Trust

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion